Syneron Medical Ltd. Launches Aesthetic Industry’s First Physician Subscription Program for Its LipoLite(TM) Laser-Assisted Lipolysis Device

YOKNEAM, ISRAEL and IRVINE, CA--(Marketwire - July 29, 2008) - Syneron™ Medical Ltd. (NASDAQ: ELOS), an innovator in the development, marketing and sales of elos™ combined-energy medical aesthetic devices, today announced the launch of the LipoLite™ Energy Access Program (LEAP), the aesthetic laser device industry’s first shared investment model. With LEAP’s cost-effective annual subscription fee, physicians of all specialties will be able to offer the increasingly popular laser-assisted lipolysis treatment.

MORE ON THIS TOPIC